{"id":8342,"date":"2025-11-13T23:02:20","date_gmt":"2025-11-13T23:02:20","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/11\/13\/kura-oncology-leukemia-komzifti\/"},"modified":"2025-11-13T23:02:20","modified_gmt":"2025-11-13T23:02:20","slug":"kura-oncology-leukemia-komzifti","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/11\/13\/kura-oncology-leukemia-komzifti\/","title":{"rendered":"STAT+: Kura Oncology secures approval for leukemia drug, its first"},"content":{"rendered":"<p>    STAT+: Kura Oncology secures approval for leukemia drug, its first<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>The Food and Drug Administration on Thursday approved a drug made by Kura Oncology to treat patients with a certain type of genetically altered leukemia.\u00a0<\/p>\n<p>The medicine will be sold under the brand name Komzifti.\u00a0<\/p>\n<p>The FDA cleared the drug to treat patients with relapsed or refractory acute myeloid leukemia, or AML, caused by a mutation in a gene called NPM1. The mutation, which makes AML more difficult to treat, is a driver of approximately 30% of all AML cases.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/11\/13\/kura-oncology-leukemia-komzifti\/?utm_campaign=rss\">Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Adam Feuerstein<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/11\/13\/kura-oncology-leukemia-komzifti\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STAT+: Kura Oncology secures approval for leukemia drug, its first The Food and Drug Administration on Thursday approved a drug made by Kura Oncology to treat patients with a certain type of genetically altered leukemia.\u00a0 The medicine will be sold under the brand name Komzifti.\u00a0 The FDA cleared the drug to treat patients with relapsed [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2154,2159,2208,2152],"tags":[2150],"class_list":["post-8342","post","type-post","status-publish","format-standard","hentry","category-biotech","category-biotechnology","category-cancer","category-drug-development","category-stat","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/8342"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=8342"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/8342\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=8342"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=8342"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=8342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}